The world of celiac disease research changes and evolves each and every day. Beyond Celiac keeps the community up-to-date on research in many ways, including our Research News Feed and the Research Opt-In.
In children on the gluten-free diet who had no symptoms but whose celiac disease blood tests and biopsies showed active celiac disease a cow's milk protein allergy might be to blame, researchers at the University of Chicago Celiac Disease report in the findings from four case studies.
As we approach the end of 2022, we are reflecting on the significant strides made this year toward finding treatments and a cure for celiac disease
Genetic tests can reveal more than a simple “yes” or “no” regarding whether an at-risk child has the genes associated with celiac disease.
Two drugs currently under study for the treatment of celiac disease are part of new collaborations between pharmaceutical companies which could result in acceleration of the drugs’ progress.
A wide-spread screening study estimates that nearly 1.5 percent of the residents of one Norwegian county have celiac disease, and before the screening, 75 percent didn’t realize it
A potential celiac disease vaccine could one day be a reality. Whenever new information is available we update our Research News and our Celiac Disease Vaccine page.
Researchers around the world are working to develop new treatments for celiac disease. As a person affected by celiac disease, you can play an important role in advancing research by participating in clinical trials. View our Clinical Trials Infographic to learn how clinical trials tie into to drug development process.
Additionally, Beyond Celiac has been directly involved with assisting a number of clinical studies in all phases. With the largest celiac disease social community, a robust email and research database and a website that receives over 2 million visits a year, we are uniquely qualified to help your clinical trial recruit qualified candidates. Learn about our patient recruitment offerings.
Our Chief Scientific Officers lead the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease.
Our Chief Scientist and Strategy Officer develops our research and funding priorities to impact patients in areas including clinical decision-making about disease management, treatment, and eventually a cure.
Learn more about our Science Team, as well as our Medical Advisory Council and Scientific Advisory Board.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to